SCHEMBL2401928

SCHEMBL2401928

C=C(C)/C=C/C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL167805 1.00
Hydrochloric Acid SCHEMBL9723617 0.97
Maleic Acid SCHEMBL6871002 0.87 TSHR (0.64)
Fumaric Acid SCHEMBL1024373 0.87 TSHR (0.64)
Fumaric Acid SCHEMBL27092735 0.87 TSHR (0.64)
Maleic Acid SCHEMBL6052835 0.87 TSHR (0.64)
Fumaric Acid SCHEMBL713345 0.87 TSHR (0.64)
Maleic Acid SCHEMBL342490 0.87 TSHR (0.64)
Maleic Acid SCHEMBL713343 0.87 TSHR (0.64)
Fumaric Acid SCHEMBL6871005 0.87 TSHR (0.64)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111757770-B 3-Phenyl-4-hexynoic acid derivatives as GPR40 agonists 赛隆制药股份公司 2023-10-03 CN disclosed
US-11111206-B2 Monomers and polymers formed thereby REGENTS OF THE UNIVERSITY OF MINNESOTA (US) 2021-09-07 US disclosed
US-20190084915-A1 MONOMERS AND POLYMERS FORMED THEREBY REGENTS OF THE UNIVERSITY OF MINNESOTA 2019-03-21 US disclosed
EP-2213666-B1 LIGUSTRAZINE AROMATIC ACID ETHER DERIVATIVE, ITS PREPARATION METHOD, PHARMACEUTICAL COMPOSITION, AND APPLICATION LI JIAMING (CN) 2012-02-15 EP disclosed
US-8012628-B2 Polymer electrochemical device KURARAY CO., LTD. (JP) 2011-09-06 US disclosed
US-7371747-B2 Cyanoalkylamino derivatives as protease inhibitors MERCK FROSST CANADA & CO. (CA) 2008-05-13 US disclosed
EP-1446115-B1 CYANOALKYLAMINO DERIVATIVES AS PROTEASE INHIBITORS MERCK FROSST CANADA LTD (CA) 2008-02-27 EP disclosed
US-20080014505-A1 POLYMER ELECTROCHEMICAL DEVICE KURARAY CO., LTD. (JP) 2008-01-17 US disclosed
EP-1870597-A2 Polymer electrochemical device Kuraray Co., Ltd. (JP) 2007-12-26 EP disclosed
EP-1446115-A4 CYANOALKYLAMINO DERIVATIVES AS PROTEASE INHIBITORS MERCK FROSST CANADA INC (CA) 2005-02-02 EP disclosed
US-20050014941-A1 Cyanoalkylamino derivatives as protease inhibitors MERCK FROSST CANADA LTD. (CA) 2005-01-20 US disclosed
EP-1446115-A2 CYANOALKYLAMINO DERIVATIVES AS PROTEASE INHIBITORS Merck Frosst Canada &amp; Co. (CA) 2004-08-18 EP disclosed
WO-2003041649-A2 CYANOALKYLAMINO DERIVATIVES AS PROTEASE INHIBITORS MERCK FROSST CANADA & CO. (CA) 2003-05-22 WO disclosed
US-4863926-A ANTICOAGULANTS, HYPOTENSIVE AGENTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1989-09-05 US disclosed
US-4782088-A HYPOTENSIVE, ANTITHROMBOTIC FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1988-11-01 US disclosed
US-4778804-A ANTICOAGULANTS, HYPOTENSIVE AGENTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1988-10-18 US disclosed
US-4767768-A ANTITHROMBIC, HYPOTENSIVE; OXIME-SUBSTITUTED FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1988-08-30 US disclosed
EP-0113106-B1 NEW NITRO ALIPHATIC COMPOUNDS, PROCESS FOR PREPARATION THEREOF AND USE THEREOF FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1986-05-14 EP disclosed
EP-0113106-A1 New nitro aliphatic compounds, process for preparation thereof and use thereof FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1984-07-11 EP disclosed